Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Physical exercise modulates the microglial complement pathway in mice to relieve cortical circuitry deficits induced by mutant human TDP-43.

Cell reports | 2023

The aggregation of TAR DNA binding protein 43 kDa (TDP-43) is related to different neurodegenerative diseases, which leads to microglial activation and neuronal loss. The molecular mechanism driving neuronal death by reactive microglia, however, has not been completely resolved. In this study, we generated a mouse model by overexpressing mutant human TDP-43 (M337V) in the primary motor cortex, leading to prominent motor-learning deficits. In vivo 2-photon imaging shows an active approach of microglia toward parvalbumin interneurons, resulting in disrupted cortical excitatory-inhibitory balance. Proteomics studies suggest that activation of the complement pathway induces microglial activity. To develop an early interventional strategy, treadmill exercise successfully prevents the deterioration of motor dysfunction under enhanced adipocytic release of clusterin to block the complement pathway. These results demonstrate a previously unrecognized pathway by which TDP-43 induces cortical deficits and provide additional insights for the mechanistic explanation of exercise training in disease intervention.

Pubmed ID: 36924491 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Antibodies used in this publication

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Ferritin monoclonal antibody, clone 5F4E3 (antibody)

RRID:AB_1674239

This monoclonal targets Ferritin monoclonal antibody clone 5F4E3

View all literature mentions

Anti Iba1, Rabbit antibody (antibody)

RRID:AB_839504

This polyclonal targets Iba1

View all literature mentions

Caspase-3 Antibody (antibody)

RRID:AB_331439

This polyclonal targets Caspase-3

View all literature mentions

Anti-NeuN (antibody)

RRID:AB_2298772

This monoclonal targets NeuN

View all literature mentions

TDP43 (D9R3L) Rabbit mAb (antibody)

RRID:AB_2800143

This monoclonal targets TDP-43

View all literature mentions

Anti-C1q antibody (antibody)

RRID:AB_2732849

This monoclonal targets C1q

View all literature mentions

C5b-9 (2A1) (antibody)

RRID:AB_1119840

This monoclonal targets Rat C5b-9

View all literature mentions

C3 (B-9) (antibody)

RRID:AB_627277

This monoclonal targets C3 (B-9)

View all literature mentions

Recombinant Anti-C3 antibody [EPR19394] (antibody)

RRID:AB_2924273

This recombinant monoclonal targets C3

View all literature mentions